Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4218331
Max Phase: Preclinical
Molecular Formula: C21H25N5S
Molecular Weight: 379.53
Molecule Type: Small molecule
Associated Items:
ID: ALA4218331
Max Phase: Preclinical
Molecular Formula: C21H25N5S
Molecular Weight: 379.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C/C(=N\NC(=N)N)c1sc(-c2ccc(C#CC3CCCCC3)cc2)nc1C
Standard InChI: InChI=1S/C21H25N5S/c1-14-19(15(2)25-26-21(22)23)27-20(24-14)18-12-10-17(11-13-18)9-8-16-6-4-3-5-7-16/h10-13,16H,3-7H2,1-2H3,(H4,22,23,26)/b25-15+
Standard InChI Key: KIXVPVUYMLKTBM-MFKUBSTISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 379.53 | Molecular Weight (Monoisotopic): 379.1831 | AlogP: 4.26 | #Rotatable Bonds: 3 |
Polar Surface Area: 87.15 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.52 | CX LogP: 4.35 | CX LogD: 3.99 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.32 | Np Likeness Score: -1.21 |
1. Elsebaei MM, Mohammad H, Abouf M, Abutaleb NS, Hegazy YA, Ghiaty A, Chen L, Zhang J, Malwal SR, Oldfield E, Seleem MN, Mayhoub AS.. (2018) Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA)., 148 [PMID:29459278] [10.1016/j.ejmech.2018.02.031] |
2. Elsebaei MM, Mohammad H, Samir A, Abutaleb NS, Norvil AB, Michie AR, Moustafa MM, Samy H, Gowher H, Seleem MN, Mayhoub AS.. (2019) Lipophilic efficient phenylthiazoles with potent undecaprenyl pyrophosphatase inhibitory activity., 175 [PMID:31075608] [10.1016/j.ejmech.2019.04.063] |
Source(1):